New test featured today in Gut, a leading international journal published by BMJ, uses A.I. to accurately predict the stages of the whole spectrum of liver diseases, from NAFLD to NASH and liver fibrosis (PRESS RELEASE) BOSTON, MA, United States, … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Technology
Tagged A.I., blood test, BMJ, cirrhosis, diagnosis, Frank Jaksch, gastroenterology journal, gut, HEPAR-QTM, hepatology journal, King’s College London, liquid biopsy, liquid biopsy test, liver biopsy, liver cancer, liver diseases, liver fibrosis, metabolic diseases diagnostics, Metadeq, NAFLD, NASH, NASH Diagnosis Problem, non-alcoholic fatty liver disease, Non-alcoholic steato-hepatitis, Non-Invasive Blood Test, novel protein biomarkers, PLIN2, predictive algorithm, Professor Geltrude Mingrone, RAB14, SDDPR, Stacey Doss
Agreement includes a clinical trial to evaluate a combination of tropifexor (LJN452) and one or more Pfizer compounds for the treatment of non-alcoholic steatohepatitis (NASH) Novartis has a leading development portfolio in non-viral liver diseases, including NASH There are currently no … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
